Drug intelligence / Profile preview

senna + lactulose

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Senna + lactulose is a combination of two laxatives that work through different mechanisms to treat constipation. Lactulose is an osmotic laxative that draws water into the intestines from surrounding body tissues, thereby softening stools and increasing their volume to stimulate bowel movement. Senna is a stimulant laxative that works by irritating the lining of the intestines, which helps stimulate muscle contractions to facilitate stool passage. This combination may be more effective than either agent alone for treating chronic constipation, particularly in elderly patients.

Brand names: Senokot-S

Beyond the preview

Go deeper on senna + lactulose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on senna + lactulose.

Explore the full profile